vimarsana.com

Page 3 - ஆம்ஸ்டர்டாம் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ProciseDx Achieves CE Mark for Fecal Calprotectin Point of Care Testing

ProciseDx Achieves CE Mark for Fecal Calprotectin Point of Care Testing News provided by Share this article Share this article SAN DIEGO, Feb. 23, 2021 /PRNewswire/  ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system. Offering a point of care test for fecal calprotectin will help many physicians expedite their diagnosis of Crohn s Disease or Ulcerative Colitis, as well as other digestive conditions. The test can be completed in under 5 minutes with the ProciseDx platform. The ProciseDx instrument is about the size of a shoe box and can provide diagnostics results in as little as 2 minutes from a finger prick drop of blood. Procise FCP uses stool from our patient home use Stool Collection Device.

Researchers discover the role of a gene involved in cardiac rhythm

Researchers discover the role of a gene involved in cardiac rhythm Researchers have used the zebrafish ( Danio rerio) to identify the role of a gene involved in cardiac rhythm, which could help explain the fundamentals of what it takes to make a human heartbeat. The University of Melbourne study also found that mutation of the gene, Tmem161b, causes potentially fatal cardiac arrhythmia. 2.5 per cent of Australians are living with cardiac arrhythmia (ABS). In 2019, it took 3090 years of potential life. Mutations in this gene may be contributing to the cause of this. Published in Proceedings of National Academy of Sciences of the United States of America (PNAS), the research could lead to better understanding and treatment of the condition in humans.

Пол, ИМТ, курение и депрессия ускоряют старение

Пол, ИМТ, курение и депрессия ускоряют старение
medicalinsider.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalinsider.ru Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.